Serum Markers as a Predictor of Response Duration and Patient Survival After Hormonal Therapy for Metastatic Carcinoma of the Prostate-Reference-Cited by-同舟云学术

Serum Markers as a Predictor of Response Duration and Patient Survival After Hormonal Therapy for Metastatic Carcinoma of the Prostate

Published:1997-04 Issue:4 Volume:157 Page:1329-1334
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Smith Joseph A.¹,Lange Paul H.¹,Janknegt Rudi A.¹,Abbou Claude C.¹,deGery Annie¹

Affiliation:

1. From the Department of Urologic Surgery, Vanderbilt University, Nashville, Tennessee, Departments of Urology, University of Washington, Seattle, Washington, University of Maastricht, Maastricht, The Netherlands, and University Hospital Henni Mondor, Aeteil and Roussel UCLAF, Romainville, France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. How much can we rely upon the level of PSA or an endpoint for evolution of clinical trials? A word of caution;Eisenberger;J. Natl Cancer Inst.,1996

2. Orchiectomy and nilutamide or placebo as treatment of metastatic prostate cancer in a multinational double-blind randomized trial;Janknegt;J. Urol.,1993

3. Chemotherapy of advanced prostatic cancer. Evaluation of response parameters;Schmidt;Urology,1976

4. Management of pain and other symptoms of advanced prostatic cancer;Labasky;Sem. Urol.,1988

5. Future directions in tumor marker technology for prostate cancer;Smith;Urol. Clin. N. Amer.,1993

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer;Journal of Modern Oncology;2021-08-16

2. High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy;Prostate Cancer;2021-04-08

3. Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer;Clinical Genitourinary Cancer;2019-08

4. Ketoconazole in Taiwanese castration-resistant prostate cancer patients: Evaluation of response rates, durations, and predictors;Urological Science;2012-06

5. Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer;Advances in Urology;2012